170 related articles for article (PubMed ID: 33300919)
1. DNA topoisomerases as additional targets for anticancer monofunctional platinum(ii) complexes.
Zhang H; Yang T; Wang Y; Wang Z; Zhu Z; Guo Z; Wang X
Dalton Trans; 2021 Jan; 50(1):304-310. PubMed ID: 33300919
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrion-targeted platinum complexes suppressing lung cancer through multiple pathways involving energy metabolism.
Zhu Z; Wang Z; Zhang C; Wang Y; Zhang H; Gan Z; Guo Z; Wang X
Chem Sci; 2019 Mar; 10(10):3089-3095. PubMed ID: 30996891
[TBL] [Abstract][Full Text] [Related]
3. Platinum complexes as inhibitors of DNA repair protein Ku70 and topoisomerase IIα in cancer cells.
Zhang H; Wang Y; Wang Y; Han Q; Yan H; Yang T; Guo Z; Wang X
Dalton Trans; 2022 Feb; 51(8):3188-3197. PubMed ID: 35113100
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Cytotoxicity of a Monofunctional Platinum Complex via a Dual-DNA-Damage Approach.
Guo Y; He Y; Wu S; Zhang S; Song D; Zhu Z; Guo Z; Wang X
Inorg Chem; 2019 Oct; 58(19):13150-13160. PubMed ID: 31539237
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.
Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM
Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968
[TBL] [Abstract][Full Text] [Related]
6. DNA-binding, topoisomerases I and II inhibition and in vitro cytotoxicity of ruthenium(II) polypyridyl complexes: [Ru(dppz)2L](2+) (L=dppz-11-CO2Me and dppz).
He X; Jin L; Tan L
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():101-9. PubMed ID: 25062055
[TBL] [Abstract][Full Text] [Related]
7. The influence of the ethane-1,2-diamine ligand on the activity of a monofunctional platinum complex.
Graziotto ME; Akerfeldt MC; Gunn AP; Yang K; Somerville MV; Coleman NV; Roberts BR; Hambley TW; New EJ
J Inorg Biochem; 2017 Dec; 177():328-334. PubMed ID: 28789807
[TBL] [Abstract][Full Text] [Related]
8. New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
Franich AA; Živković MD; Ilić-Tomić T; Đorđević IS; Nikodinović-Runić J; Pavić A; Janjić GV; Rajković S
J Biol Inorg Chem; 2020 May; 25(3):395-409. PubMed ID: 32162071
[TBL] [Abstract][Full Text] [Related]
9. Dihydroxylated 2,4,6-triphenyl pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study.
Karki R; Thapa P; Yoo HY; Kadayat TM; Park PH; Na Y; Lee E; Jeon KH; Cho WJ; Choi H; Kwon Y; Lee ES
Eur J Med Chem; 2012 Mar; 49():219-28. PubMed ID: 22318164
[TBL] [Abstract][Full Text] [Related]
10. Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells.
Pan X; Hartley JM; Hartley JA; White KN; Wang Z; Bligh SW
Phytomedicine; 2012 May; 19(7):618-24. PubMed ID: 22402246
[TBL] [Abstract][Full Text] [Related]
11. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.
Lo YC; Ko TP; Su WC; Su TL; Wang AH
J Inorg Biochem; 2009 Jul; 103(7):1082-92. PubMed ID: 19525010
[TBL] [Abstract][Full Text] [Related]
12. Anticancer Activity of Platinum (II) Complex with 2-Benzoylpyridine by Induction of DNA Damage, S-Phase Arrest, and Apoptosis.
Li YL; Gan XL; Zhu RP; Wang X; Liao DF; Jin J; Huang Z
Anticancer Agents Med Chem; 2020; 20(4):504-517. PubMed ID: 31721706
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerases as anticancer targets.
Delgado JL; Hsieh CM; Chan NL; Hiasa H
Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
[TBL] [Abstract][Full Text] [Related]
14. Iridium(iii) complexes as mitochondrial topoisomerase inhibitors against cisplatin-resistant cancer cells.
He L; Xiong K; Wang L; Guan R; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2021 Aug; 57(67):8308-8311. PubMed ID: 34319315
[TBL] [Abstract][Full Text] [Related]
15. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
16. Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes.
Jin S; Hao Y; Zhu Z; Muhammad N; Zhang Z; Wang K; Guo Y; Guo Z; Wang X
Inorg Chem; 2018 Sep; 57(17):11135-11145. PubMed ID: 30117731
[TBL] [Abstract][Full Text] [Related]
17. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
Margiotta N; Savino S; Gandin V; Marzano C; Natile G
ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
[TBL] [Abstract][Full Text] [Related]
18. DNA topoisomerases as molecular targets for anticancer drugs.
Buzun K; Bielawska A; Bielawski K; Gornowicz A
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1781-1799. PubMed ID: 32975138
[TBL] [Abstract][Full Text] [Related]
19. Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors.
Arepalli SK; Lee C; Sim S; Lee K; Jo H; Jun KY; Kwon Y; Kang JS; Jung JK; Lee H
Bioorg Med Chem; 2018 Oct; 26(18):5181-5193. PubMed ID: 30253887
[TBL] [Abstract][Full Text] [Related]
20. Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.
Preet R; Mohapatra P; Mohanty S; Sahu SK; Choudhuri T; Wyatt MD; Kundu CN
Int J Cancer; 2012 Apr; 130(7):1660-70. PubMed ID: 21544805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]